Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM)
- PMID: 24119109
- DOI: 10.1111/ajt.12465
Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM)
Abstract
In a reference set of 403 kidney transplant biopsies, we recently developed a microarray-based test that diagnoses antibody-mediated rejection (ABMR) by assigning an ABMR score. To validate the ABMR score and assess its potential impact on practice, we performed the present prospective INTERCOM study (clinicaltrials.gov NCT01299168) in 300 new biopsies (264 patients) from six centers: Baltimore, Barcelona, Edmonton, Hannover, Manchester and Minneapolis. We assigned ABMR scores using the classifier created in the reference set and compared it to conventional assessment as documented in the pathology reports. INTERCOM documented uncertainty in conventional assessment: In 41% of biopsies where ABMR features were noted, the recorded diagnoses did not mention ABMR. The ABMR score correlated with ABMR histologic lesions and donor-specific antibodies, but not with T cell-mediated rejection lesions. The agreement between ABMR scores and conventional assessment was identical to that in the reference set (accuracy 85%). The ABMR score was more strongly associated with failure than conventional assessment, and when the ABMR score and conventional assessment disagreed, only the ABMR score was associated with early progression to failure. INTERCOM confirms the need to reduce uncertainty in the diagnosis of ABMR, and demonstrates the potential of the ABMR score to impact practice.
Keywords: Antibody-mediated rejection; classifier; kidney transplant; microarrays; molecular diagnostics.
© Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons.
Similar articles
-
A Probabilistic Approach to Histologic Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Biopsies.Am J Transplant. 2017 Jan;17(1):129-139. doi: 10.1111/ajt.13934. Epub 2016 Aug 3. Am J Transplant. 2017. PMID: 27340822
-
Potential impact of microarray diagnosis of T cell-mediated rejection in kidney transplants: The INTERCOM study.Am J Transplant. 2013 Sep;13(9):2352-63. doi: 10.1111/ajt.12387. Epub 2013 Aug 5. Am J Transplant. 2013. PMID: 23915426 Clinical Trial.
-
Donor-Specific Antibody Is Associated with Increased Expression of Rejection Transcripts in Renal Transplant Biopsies Classified as No Rejection.J Am Soc Nephrol. 2021 Nov;32(11):2743-2758. doi: 10.1681/ASN.2021040433. Epub 2021 Jul 12. J Am Soc Nephrol. 2021. PMID: 34253587 Free PMC article.
-
New insights in antibody-mediated rejection.Curr Opin Nephrol Hypertens. 2014 Nov;23(6):597-604. doi: 10.1097/MNH.0000000000000069. Curr Opin Nephrol Hypertens. 2014. PMID: 25211610 Review.
-
Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.Curr Opin Organ Transplant. 2010 Feb;15(1):42-8. doi: 10.1097/MOT.0b013e3283352a50. Curr Opin Organ Transplant. 2010. PMID: 20009933 Review.
Cited by
-
Molecular Assessment of C4d-Positive Renal Transplant Biopsies Without Evidence of Rejection.Kidney Int Rep. 2018 Sep 18;4(1):148-158. doi: 10.1016/j.ekir.2018.09.005. eCollection 2019 Jan. Kidney Int Rep. 2018. PMID: 30596178 Free PMC article.
-
Advances in single-cell sequencing: insights from organ transplantation.Mil Med Res. 2021 Aug 13;8(1):45. doi: 10.1186/s40779-021-00336-1. Mil Med Res. 2021. PMID: 34389057 Free PMC article. Review.
-
Antibody-mediated rejection of renal allografts: diagnostic pitfalls and challenges.Physiol Res. 2021 Dec 30;70(Suppl4):S551-S565. doi: 10.33549/physiolres.934801. Physiol Res. 2021. PMID: 35199543 Free PMC article. Review.
-
Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection.J Am Soc Nephrol. 2014 Oct;25(10):2267-77. doi: 10.1681/ASN.2013111149. Epub 2014 Apr 3. J Am Soc Nephrol. 2014. PMID: 24700874 Free PMC article.
-
Endocan as a marker of microvascular inflammation in kidney transplant recipients.Sci Rep. 2019 Feb 12;9(1):1854. doi: 10.1038/s41598-018-37975-9. Sci Rep. 2019. PMID: 30755622 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical